Dr. Reddy’s Laboratories Limited Form 6-K Filing

Dr. Reddy’s Laboratories Limited, a foreign private issuer, submitted a Form 6-K to the Securities and Exchange Commission (SEC) in October 2025. The filing includes an intimation dated October 24, 2025, as an exhibit. The form indicates that the registrant files annual reports under Form 20-F and is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or 101(b)(7). The registrant is also not furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. The filing was signed by K Randhir Singh, the Company Secretary of Dr. Reddy’s Laboratories Limited.